Skip to main content
logo
TLC BioSciences Corp. (TPEX:7924)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
195.50
-15.00 (-7.13%)
At close: Jul 29, 2026

TLC BioSciences Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Cash & Equivalents
694.74616.41
Short-Term Investments
-766.49
Cash & Short-Term Investments
694.741,383
Cash Growth
-49.76%-
Receivables
20.4920.38
Inventory
41.4461.52
Prepaid Expenses
165.43224.69
Other Current Assets
22.0532.24
Total Current Assets
944.151,722
Property, Plant & Equipment
549.37480.91
Other Intangible Assets
0.941.47
Other Long-Term Assets
24.1826.85
Total Assets
1,5192,231

Liabilities

Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Accounts Payable
-16.21
Current Portion of Long-Term Debt
879.331,245
Current Portion of Leases
20.1119.62
Current Unearned Revenue
2.525.12
Other Current Liabilities
4,2143,999
Total Current Liabilities
5,1165,285
Long-Term Debt
33.2139.65
Long-Term Leases
23.3215.25
Long-Term Unearned Revenue
23.5624.07
Other Long-Term Liabilities
1.84.66
Total Liabilities
5,1985,369

Shareholders' Equity

Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Common Stock
0.260.26
Additional Paid-In Capital
9,6189,555
Retained Earnings
-13,311-12,657
Comprehensive Income & Other
12.88-35.84
Total Common Equity
-3,680-3,138
Shareholders' Equity
-3,680-3,138
Total Liabilities & Equity
1,5192,231

Additional Metrics

Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Total Debt
955.971,319
Net Cash (Debt)
-261.2363.44
Net Cash Growth
--
Net Cash Per Share
-3.140.83
Filing Date Shares Outstanding
83.3276.69
Total Common Shares Outstanding
83.3276.69
Working Capital
-4,172-3,563
Book Value Per Share
-44.16-40.92
Tangible Book Value
-3,681-3,139
Tangible Book Value Per Share
-44.17-40.93